FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,117 letters match. Newest first.

  1. Fancystage Unipessoal, LDA

    Portugal OTC drug maker Fancystage Unipessoal skipped identity testing of high-risk ingredients and lacked quality-unit control, FDA says.

    High risk
  2. Avaria Health & Beauty Corp.

    FDA cites Avaria Health & Beauty for manufacturing-rule violations in OTC drugs, including missing glycerin identity testing and weak quality unit.

    High risk
  3. Tan Alize Kozmetik Ve Temizlik Urunleri

    FDA warns Turkish OTC drug maker Tan Alize over missing glycerin identity testing and a weak quality unit; import alert issued.

    High risk
  4. LCC Ltd.

    LCC Ltd., an OTC drug maker, lacked identity testing for risky ingredients and adequate quality oversight, FDA says.

    High risk
  5. Suhan Aerosol

    Suhan Aerosol, an Indian OTC drug maker, failed to test high-risk ingredients for toxic diethylene/ethylene glycol and lacked quality oversight.

    High risk
  6. Skyline Herbals Private Limited

    FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.

    High risk
  7. Daxal Cosmetics Private Limited

    FDA warns Daxal Cosmetics for refusing records on over-the-counter drugs, including toothpaste, at risk for diethylene glycol and ethylene glycol contamination.

    High risk
  8. Orchid Lifesciences

    FDA warns Orchid Lifesciences over over-the-counter drug testing gaps and weak quality unit.

    High risk
  9. STC India Private Limited

    FDA warned STC India over insanitary conditions and missing Salmonella controls for ready-to-eat mukhwas.

    High risk
  10. Intas Pharmaceuticals Limited

    FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.

    High risk
  11. Baxter Healthcare Corporation

    FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.

    High risk
  12. Centaur Pharmaceuticals Private Ltd.

    FDA says Centaur Pharmaceuticals drugs were adulterated due to inadequate cleaning and cross-contamination.

    High risk
  13. Medgel Private Limited

    FDA cited Medgel Private Limited, an Indian OTC drug maker, for manufacturing violations including poor investigations and data integrity failures.

    High risk
  14. Iso-Tex Diagnostics, Inc.

    FDA warns Iso-Tex Diagnostics over manufacturing violations that risk contamination of sterile radiopharmaceutical drugs.

    High risk
  15. Avlon Industries, Inc.

    FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.

    High risk
  16. LXR Biotech, LLC

    FDA says LXR Biotech, a contract maker of an OTC drug, shipped batches without testing components or finished product.

    High risk
  17. Jamol Laboratories, Inc.

    FDA found Jamol Laboratories making a nasal emollient under insanitary conditions and without adequate quality control, lab testing, or process validation.

    High risk
  18. Porfirios Italian Foods, Inc.

    FDA says Porfirios Italian Foods made pasta under insanitary conditions without a required food safety plan.

    High risk
  19. RenatiLabs Inc.

    RenatiLabs marketed WJMAX, a human umbilical cord-derived biologic, without a license and released a lot that failed sterility testing.

    High risk
  20. Northland Vapor Company, LLC

    FDA warns Northland Vapor that Delta-8 THC gummy bears are adulterated with an unsafe additive and made under insanitary conditions.

    High risk
  21. Baits and Sea Foods, S.A.

    FDA warns Baits and Sea Foods, S.A. over missing histamine, botulinum and allergen controls in mahi-mahi HACCP plan.

    High risk
  22. Stratus Biosystems, LLC dba CellGenuity Regenerative Science

    FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.

    High risk
  23. Chean Industries Dominicana S.R.L.

    FDA warns Chean Industries Dominicana over dried sea cucumbers lacking HACCP controls and sanitation records.

    High risk
  24. Fuller Industries Inc.

    FDA warns Fuller Industries over current good manufacturing practice violations in OTC hand soaps and sanitizers, including quality oversight and ingredient testing.

    High risk
  25. Eden’s Answers, Inc.

    Eden’s Answers dietary supplements are adulterated by manufacturing-rule violations and misbranded by label omissions.

    Medium
  26. Edge Biologicals Inc.

    FDA cited Edge Biologicals Inc. for repeated quality-system violations in its IVD culture media devices, including unvalidated cleaning and sterilization.

    High risk
  27. Centaur Pharmaceuticals Private Ltd.

    FDA warns Centaur Pharmaceuticals over manufacturing practice failures in active ingredients, including records and cleaning.

    High risk
  28. Marumo Co., Ltd.

    FDA warned Marumo Co. that its dried shaved skipjack tuna was adulterated because its seafood HACCP plan and sanitation controls were inadequate.

    High risk
  29. Fukusui Shoji Ltd.

    FDA warned Fukusui Shoji Ltd. that its fresh fish safety plan has serious gaps that make the fish unsafe under the law.

    High risk
  30. New Manna Food

    FDA warns New Manna Food of Guam about tuna salad sandwich HACCP, label, and registration violations.

    High risk
  31. NeilMed Pharmaceuticals Inc.

    FDA warned NeilMed Pharmaceuticals that its OTC drug manufacturing had current good manufacturing practice violations, including missing glycerin identity testing and dirty equipment.

    High risk
  32. Brand Packaging Group, Inc.

    Brand Packaging Group, a Farmingdale, NY dietary supplement maker, failed to test finished batches and ingredient identity, FDA found.

    High risk
  33. Chengdu KeCheng Fine Chemicals Co., Ltd.

    FDA placed Chengdu KeCheng's APIs on import alert after it ignored FDA records requests.

    High risk
  34. Schwebel Baking Company

    FDA warned Schwebel Baking that its Hebron, Ohio ready-to-eat bun plant had sesame allergen cross-contact and pest problems.

    High risk
  35. Vitang Technology LLC

    Vitang Technology sold dental aligners designed with uncleared software without a new 510(k) and with quality system failures.

    High risk
  36. Mr. Lulu LLC

    FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.

    High risk
  37. Steiner Biotechnology, LLC

    FDA found Steiner Biotechnology's implantable dental bone grafts had design, sterilization, and cleanroom failures and were marketed beyond cleared uses.

    High risk
  38. RemedyRepack, Inc.

    RemedyRepack, a drug repackager in Indiana, Pennsylvania, failed CGMP, including cleaning and beta-lactam cross-contamination controls.

    High risk
  39. Manzanola Feeds, LLC

    Manzanola Feeds' alfalfa horse cubes contained Clostridium botulinum toxin type C and animal hair, causing an outbreak and recall.

    High risk
  40. Yichang Jiayuan Foodstuffs Co., Ltd

    FDA says Yichang Jiayuan Foodstuffs packed ready-to-eat mandarin oranges under insanitary conditions because glass controls failed.

    High risk
  41. New England Life Care, Inc. dba Advanced Compounding Solutions

    FDA cites Advanced Compounding Solutions for insanitary sterile-drug production and CGMP failures after a 2022 inspection.

    High risk
  42. Rhodes Legacy Inc DBA Sun Sprouts

    Rhodes Legacy, doing business as Sun Sprouts, cited after Salmonella outbreak over untested sprouts and insanitary conditions.

    High risk
  43. I.T.S. GmbH

    Austrian maker I.T.S. GmbH was cited for quality-system, device history record, and medical device reporting failures for bone fixation and implantable orthopedic devices.

    Medium
  44. Champaklal Maganlal Homeo Pharmacy Private Limited

    FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.

    High risk
  45. Sure-Biochem Laboratories, LLC

    FDA says contract lab Sure-Biochem missed Burkholderia cepacia in drug samples and cites broad CGMP failures.

    High risk
  46. Pharmedica USA, LLC

    FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.

    High risk
  47. Gary’s Cheesecakes & Fine Desserts

    FDA cited Gary’s Cheesecakes & Fine Desserts for pest activity in its ready-to-eat bakery plant and failure to register the facility.

    High risk
  48. EarthLab, Inc., dba Wise Woman Herbals

    FDA warned EarthLab, doing business as Wise Woman Herbals, over unapproved drug claims and supplement CGMP violations.

    High risk
  49. Sea-Long Medical Systems, LLC

    FDA warns Sea-Long Medical Systems over Treatment Hood quality failures and unapproved uses.

    High risk
  50. Drivergent, Inc.

    Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.

    High risk